Page results
-
Our annual members' meeting (AMM) brings together members, governors and staff, and is where our governors officially receive our annual report and accounts.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
Information about staff who work in the Macmillan Support and Information Service.
-
This information aims to support and supplement the information provided in the Be Active video available on uclh.nhs.uk/wellbeing
-
Health and wellbeing information for people affected by cancer.
-
This information explains when planned caesareans would be provided at The Whittington Hospital for women having antenatal care at UCLH.
-
Latest news and developments in the Macmillan Support and Information Service
-
Events, classes and workshops at the Macmillan Support and Information Service (MSIS)
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
File results
-
FOI/2022/0315 - Role of patient safety specialists within the Trust
-
FOI/2022/0317 - Inpatient mental health facilities
-
FOI/2022/0318 - HIMMS Electronic Medical Record Adoption Model (EMRAM) level achieved at Trust
-
FOI/2022/0325 - Number of patients on the public RTT pathway
-
FOI/2022/0327 - Data Protection Officer job description
-
FOI/2022/0328 - Treatment for migraine
-
FOI/2022/0330 - Sleep and respiratory services
-
FOI/2022/0333 - Maternity care report
-
FOI/2022/0338 - X-ray reporting and interpretation of nasogastric tube placement
-
FOI/2022/0344 - Patient Administration System (PAS) used at Trust